Table 1 Clinical characteristics of study participants.

From: Identification of potential biomarkers and pathways involved in high-altitude pulmonary edema using GC-MS and LC-MS metabolomic methods

Characteristics

Control (n = 21)

HAPE (n = 24)

P value

Sex (M/F)

21/0

24/0

—

Age, year

23 (21, 26)

23 (22, 25.75)

0.630

Body mass index, kg/m2

22.03 ± 1.28

22.16 ± 1.34

0.734

Temperature, ℃

36.5 (36.35, 36.6)

36.8 (36.5, 37.73)

0.010

Heart rate, beats/min

89.90 ± 14.13

111.38 ± 13.01

< 0.0001

Respiratory rate, breaths/min

18 (16, 20)

22 (20, 22)

< 0.0001

Systolic blood pressure, mmHg

122.05 ± 8.63

123.29 ± 14.03

0.719

Diastolic blood pressure, mmHg

76.81 ± 9.29

84.50 ± 14.49

0.038

Pulse oxygen saturation, %

85 (80.5, 87)

75 (59.25, 80.75)

< 0.0001

Lake Louise Score

0 (0, 1)

5 (4, 6)

< 0.0001

Headache

0 (0, 0)

2 (1, 2)

< 0.0001

Gastrointestinal symptoms

0 (0, 0)

1 (0, 1)

< 0.0001

Fatigue and/or weakness

0 (0, 1)

2 (1.25, 2)

< 0.0001

Dizziness/light-headedness

0 (0, 0)

1 (0, 2)

0.0005